Brief: Supernus Announces Third Quarter 2022 Financial Results
08/11/2022 23:21
Nov 8 (Reuters) - Supernus Pharmaceuticals Inc SUPN.O :
* SUPERNUS ANNOUNCES THIRD QUARTER 2022 FINANCIAL RESULTS
* SUPERNUS PHARMACEUTICALS INC - QTRLY REVENUE OF $177.4
MILLION,
UP 19%
* SUPERNUS PHARMACEUTICALS INC - QTRLY EPS $0.03
* SUPERNUS PHARMACEUTICALS INC - SEES FY REVENUE $650
MILLION -
$680 MILLION
Source text for Eikon: ID:nGNXc9Y4yg
Further company coverage: SUPN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Supernus Pharmaceuticals
See all newsHuron Consulting poised to hit fresh record ahead of S&P SmallCap addition
Brief: S&P Dow Jones Indices Msg Rangers And Huron Consulting Group Set To Join S&P Smallcap 600
Brief: Supernus Pharmaceuticals Says FDA Grants Seven Years Orphan-Drug Exclusivity For Onapgo
Supernus Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
U.S. STOCKS ON THE MOVE -Micron Technology, Ares Management, Boeing